CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $367,000 | -10.7% | 89,400 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $411,000 | -4.6% | 94,800 | +11.0% | 0.00% | -20.0% |
| Q1 2021 | $431,000 | +643.1% | 85,400 | +532.6% | 0.01% | +400.0% |
| Q3 2020 | $58,000 | -94.3% | 13,500 | -92.3% | 0.00% | -92.9% |
| Q2 2020 | $1,022,000 | +73.5% | 174,286 | +245.1% | 0.01% | -56.2% |
| Q2 2018 | $589,000 | -15.0% | 50,500 | +87.9% | 0.03% | -38.5% |
| Q1 2018 | $693,000 | – | 26,871 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |